NISHANT GUPTA: Open Payments
NPI 1699270710 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 49 payments from 10 companies in 2025. Trend: 2023 $45 · 2024 $392 · 2025 $1,435
Food & beverage: $1,426Education: $9
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $329 |
| Neurocrine BioSciences, Inc. | 7 | $303 |
| Otsuka America Pharmaceutical, Inc. | 5 | $186 |
| E.R. Squibb & Sons, L.L.C. | 4 | $164 |
| Alpha Cognition USA, Inc. | 2 | $156 |
| Novo Nordisk Inc | 1 | $119 |
| Eisai Inc. | 1 | $112 |
| Lundbeck LLC | 1 | $25 |
| Surgenex LLC | 1 | $24 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
Products named: AUSTEDO XR, INGREZZA, REXULTI, COBENFY, Zunveyl, Ozempic, Leqembi, SurGraft.
Industry payments across FL — which companies pay providers there.
